Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
24
Frequently Asked Questions
What is Market Cap of Lantern Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lantern Pharma Inc market cap is $46.55M.
What is the 52-week high for Lantern Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lantern Pharma Inc 52 week high is $6.12 as of September 07, 2025.
What is the 52-week low for Lantern Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lantern Pharma Inc 52 week low is $2.55 as of September 07, 2025.
What is Lantern Pharma Inc stock price today?
Lantern Pharma Inc stock price today is $4.31.
What was Lantern Pharma Inc stock price yesterday?
Lantern Pharma Inc stock price yesterday was $4.20.
What is the PE ratio of Lantern Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lantern Pharma Inc’s P/E ratio is -2.41.
What is the Price-to-Book ratio of Lantern Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lantern Pharma Inc P/B ratio is 3.7119.
What is the 50-day moving average of Lantern Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lantern Pharma Inc 50-day moving average is $4.13.
